This site is part of the Global Exhibitions Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.



  • Flu Study Yields New Vaccine Technology
    Vaccines to protect against an avian influenza pandemic as well as seasonal flu may be mass produced more quickly and efficiently using technology described today (Sept. 2) by researchers at the University of Wisconsin-Madison in the journal Nature Communications. The new ...More
    2 days ago Posted in News
  • Ebola Vaccine Clinical Trial Opens at Sanford Health
    Sanford Health is seeking participants to enroll in clinical trial testing a vaccine for the Ebola virus. The Merck-sponsored study will explore the vaccine’s ability to safely generate antibodies that could protect against future exposure to the virus. The clinical ...More
    1 week ago Posted in News
  • Less May Be More in Slowing Cholera Epidemics
    An oral cholera vaccine that is in short supply could treat more people and save more lives in crisis situations, if one dose were dispensed instead of the recommended two, new Johns Hopkins Bloomberg School of Public Health research suggests. More than 1.5 billion people ...More
    2 weeks ago Posted in News
  • ACIP Recommendations for Use of Seasonal Influenza Vaccines
    The Aug. 7, 2015 issue of the CDC's Morbidity and Mortality Weekly Report (MMWR) provides a report that updates the 2014 recommendations of the Advisory Committee on Immunization Practices (ACIP) regarding the use of seasonal influenza vaccines. Updated information for the ...More
    2 weeks ago Posted in News
  • Influenza Vaccines Provide Moderate Protection Throughout the Entire Flu Season
    Individuals who received the flu vaccine were protected for up to six months post-vaccination, the duration of most flu seasons, according to a study presented at the 2015 International Conference on Emerging Infectious Diseases. Each flu season, researchers work to ...More
    2 weeks ago Posted in News
  • New Study Makes Major Advance Toward More Effective, Long-Lasting Flu Vaccine
    Scientists from the Scripps Research Institute (TSRI) and the Janssen Pharmaceutical Companies of Johnson & Johnson have found a way to induce antibodies to fight a wide range of influenza subtypes—work that could one day eliminate the need for repeated seasonal ...More
    2 weeks ago Posted in News
  • Animal Trial to Test Promising Vaccine for H1N1
    An H1N1 vaccine developed at the University of Nebraska Medical Center will enter a definitive round of testing this month, and researchers hope to establish its ability to ward off the virus. Made possible by a licensing deal brokered through UNMC's technology transfer ...More
    3 weeks ago Posted in News
  • Synthetic DNA Vaccine Against MERS Induces Immunity
    A novel synthetic DNA vaccine can, for the first time, induce protective immunity against the Middle East Respiratory Syndrome (MERS) coronavirus in animal species, reported researchers from the Perelman School of Medicine at the University of Pennsylvania. ...More
    3 weeks ago Posted in News
  • NIH Scientists Successfully Test MERS Vaccine in Monkeys and Camels
    National Institutes of Health (NIH) scientists and colleagues report that an experimental vaccine given six weeks before exposure to Middle East respiratory syndrome coronavirus (MERS-CoV) fully protects rhesus macaques from disease. The vaccine also generated potentially ...More
    3 weeks ago Posted in News
  • Development of New Anthrax Vaccine is Underway
    A new anthrax vaccine that could be easier and faster to produce than the existing licensed product will undergo initial clinical studies through an agreement between the U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness ...More
    3 weeks ago Posted in News
« Previous1234567891011105106Next »